Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kate Rappard"'
Autor:
Carmen Ruiz-Velasco, Peter Kuhn, James Hicks, Amado Zurita, Paul Corn, Paymaneh Malihi, Ching-Ju Hsu, Kai-Han Tu, Rafael Nevarez, Anand Kolatkar, Katherine Cunningham, Kate Rappard, Benjamin Ormseth, Ana Aparicio, Chen-Ching Peng, Ryan Storgard, Nicholas Matsumoto, Shoujie Chai
S1. Platelet confirmation with CD61 staining in the SKBR3-spiked NBD sample S2. Enumeration of CTC subtypes S3. Survival analysis using AVPC-MS-CTC status S4. Survival analysis in patients without pc.CTC S5. Treatment decision tree Table S1. Correlat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4cb16e971fcddcd2359dbd8e3df042
https://doi.org/10.1158/1541-7786.22526709
https://doi.org/10.1158/1541-7786.22526709
Autor:
Carmen Ruiz-Velasco, Peter Kuhn, James Hicks, Amado Zurita, Paul Corn, Paymaneh Malihi, Ching-Ju Hsu, Kai-Han Tu, Rafael Nevarez, Anand Kolatkar, Katherine Cunningham, Kate Rappard, Benjamin Ormseth, Ana Aparicio, Chen-Ching Peng, Ryan Storgard, Nicholas Matsumoto, Shoujie Chai
Metastatic castration-resistant prostate cancer (mCRPC) includes a subset of patients with particularly unfavorable prognosis characterized by combined defects in at least two of three tumor suppressor genes: PTEN, RB1, and TP53 as aggressive variant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::607dfc7168091377c8cbad1625e33931
https://doi.org/10.1158/1541-7786.c.6545181.v1
https://doi.org/10.1158/1541-7786.c.6545181.v1
Autor:
Nicholas Matsumoto, Kai-Han Tu, Shoujie Chai, Chen-Ching Peng, Benjamin Ormseth, Katherine Cunningham, Ana Aparicio, Rafael Nevarez, Ching-Ju Hsu, Ryan Storgard, Peter Kuhn, Paymaneh D. Malihi, Kate Rappard, Anand Kolatkar, Carmen Ruiz-Velasco, Amado J. Zurita, Paul G. Corn, James W. Hicks
Publikováno v:
Molecular Cancer Research. 19:2036-2045
Metastatic castration-resistant prostate cancer (mCRPC) includes a subset of patients with particularly unfavorable prognosis characterized by combined defects in at least two of three tumor suppressor genes: PTEN, RB1, and TP53 as aggressive variant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56552bc7b490c69dce0f089851cdf65d
https://doi.org/10.1158/1541-7786.mcr-21-0383
https://doi.org/10.1158/1541-7786.mcr-21-0383
Autor:
Shoujie Chai, Nicholas Matsumoto, Ryan Storgard, Chen-Ching Peng, Ana Aparicio, Benjamin Ormseth, Kate Rappard, Cunningham Kate, Anand Kolatkar, Rafael Nevarez, Kai Han Tu, Ching-Ju Hsu, Amin Naghdloo, Paymaneh Malihi, Liya Xu, Paul Corn, Amado Zurita-Saavedra, James Hicks, Carmen Ruiz-Velasco, Peter Kuhn
Publikováno v:
Cancer Research. 82:1957-1957
Background: The mutation, selection, and adaptation of tumor cells along disease progression exhibits a spectrum of phenotypic and genotypic heterogeneity. The importance of distinguishing phenotypic states of CTC in addition to genomic alterations h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1fa64075a67e505d8314f66947718b9
https://doi.org/10.1158/1538-7445.am2022-1957
https://doi.org/10.1158/1538-7445.am2022-1957